FDA Announces New Center for Real-World Evidence Innovation
December 16, 2024Policy & Regulation, Health Care, Policy, Food and Drug Administration (FDA)
On December 12, 2024, FDA’s Center for Drug Evaluation and Research (CDER) announced a new CDER Center for Real-World Evidence Innovation (CCRI). The CCRI is intended to serve as the focal point to promote more efficient and consistent communications across CDER offices regarding real-world data (RWD) and real-world evidence (RWE).
Search Results
Get the latest FDA and related regulatory developments critical to the life sciences industry delivered to your inbox.
